Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP-671 in patients with gout
CTR20233710Phase 3Active
- Sponsor
- Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lingdolinurad in gout, sponsored by Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.. Started Dec 2023; status: active.
02
Drugs
lingdolinurad
03
Conditions
gout
Beyond the preview
Go deeper on CTR20233710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233710.